Prevention of cardioembolic stroke (Q26866343)

publication date

March 2012

1 reference

1 reference

27 Suppl 1

1 reference

PubMed

page(s)

15-26

1 reference

Advances in the prevention of cerebral ischaemia due to atrial fibrillation

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Prevalence of stroke and transient ischemic attack in three elderly populations of central Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Evaluation of costs and outcome in cardioembolic stroke or TIA

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

[Diagnosis and secondary prevention measures in patients hospitalized for cerebral infarction in Spain. The DIAPRESIC study]

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Cardioembolic stroke: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Guía de práctica clínica sobre prevención primaria y secundaria del ictus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

The use of diagnostic tests in patients with acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2.6-fold in patients with acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Detection of paroxysmal atrial fibrillation in acute stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Transoesophageal echocardiography in patients with acute stroke with sinus rhythm and no cardiac disease history.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Effect of dronedarone on cardiovascular events in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial [...]

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Dronedarone in High-Risk Permanent Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Anticoagulation in atrial fibrillation: selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

The net clinical benefit of warfarin anticoagulation in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Newly identified events in the RE-LY trial

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Apixaban in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

A new era for anticoagulation in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

An update on cardioembolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Long-term effect of chronic oral anticoagulation with warfarin after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021

Venice Chart international consensus document on atrial fibrillation ablation.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2812%2970004-X

7 January 2021